The Role of Radiation Therapy
At a Glance
Most spinal meningiomas are benign and can be completely removed with surgery, so radiation is not routinely needed. Doctors may consider it when tumor remains after surgery, returns, cannot be safely removed, or is higher grade, while carefully protecting the spinal cord.
For the vast majority of patients with a spinal meningioma, surgery is the only treatment needed. Because most of these tumors are benign (WHO Grade 1) and can be removed completely, radiation is generally not a standard part of the initial treatment plan [1][2].
However, there are specific situations where your medical team may recommend radiation therapy as an additional tool.
When is Radiation Considered?
Radiation is typically reserved for “complex” cases rather than routine ones. Your doctor might discuss radiation with you if:
- Subtotal Resection: The tumor was attached to a critical nerve or blood vessel, and the surgeon intentionally left a small piece behind to avoid causing permanent damage [1][3].
- Recurrence: The tumor has grown back after a previous surgery [1].
- Higher Grade: The pathology report shows the tumor is a WHO Grade 2 (atypical) or WHO Grade 3 (malignant), which have a higher risk of returning [4][5].
- Inoperable Tumors: The tumor is in a location where surgery is considered too dangerous for your overall health or neurological function [1].
The Grade 2 Controversy
There is currently no universal consensus on whether every WHO Grade 2 spinal meningioma needs radiation after surgery. Some studies show that if the surgeon was able to remove the entire tumor, the risk of it coming back is low enough that radiation can be avoided [6]. Other experts suggest that because Grade 2 cells are more active, radiation should be considered even after a “clean” surgery to be safe [4]. This decision is usually made on a case-by-case basis by a multidisciplinary tumor board.
Protecting the Spinal Cord and Managing Risks
The biggest challenge with radiating the spine is that the spinal cord is extremely sensitive to radiation. Doctors must balance the dose needed to target tumor cells with the tolerance limits of the healthy spinal cord [7].
- Radiation Myelopathy: This is a rare but serious complication where radiation damages the spinal cord, potentially causing weakness or numbness months or years after treatment [8][9].
- Dose Limits: To prevent this, radiation oncologists use evidence-based, fractionation-specific dose-volume constraints on the amount of radiation the cord receives [7].
Radiation can also cause side effects like significant fatigue, skin or pain reactions, a small long-term risk of secondary malignancy, and an increased risk of vertebral fracture in the treated area.
Types of Radiation Therapy
There are two main ways radiation is delivered to the spine:
- Stereotactic Body Radiation Therapy (SBRT) / Radiosurgery: This technique uses highly focused, high-dose beams to target the tumor with pinpoint accuracy, usually in 1 to 5 sessions [10][11]. It is often used for small, well-defined areas of tumor [10].
- Fractionated Radiotherapy: This involves giving much smaller doses of radiation every day for several weeks (usually 25–30 sessions) [7]. This approach is often chosen based on geometry, tumor size, or if the cord is already showing signs of pressure or swelling [10][8].
By spreading the dose out over many days, normal tissues have time to recover, which helps clinicians meet spinal-cord safety constraints [7]. Your radiation oncologist will use a combination of MRI and CT scans to create a 3D map of your spine to ensure the beams are as precise as possible [12].
Common questions in this guide
Do all spinal meningiomas need radiation after surgery?
When might radiation be recommended for a spinal meningioma?
What is the difference between SBRT and fractionated radiation?
What are the risks of radiation near the spinal cord?
Does a WHO Grade 2 spinal meningioma always need radiation?
Can I monitor a remaining spinal meningioma instead of starting radiation?
Get notified when new evidence is published on Spinal meningioma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Spinal meningiomas.
Hohenberger C, Hau P, Schebesch KM, et al.
Neuro-oncology advances 2023; (5(Suppl 1)):i112-i121 doi:10.1093/noajnl/vdad013.
PMID: 37287574 - 2
Low recurrence after Simpson grade II resection of spinal benign meningiomas in a single-institute 10-year retrospective study.
Naito K, Yamagata T, Arima H, Takami T
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020; (77()):168-174 doi:10.1016/j.jocn.2020.04.113.
PMID: 32360158 - 3
Treatment outcomes of 17 patients with atypical spinal meningioma, including 4 with metastases: a retrospective observational study.
Noh SH, Kim KH, Shin DA, et al.
The spine journal : official journal of the North American Spine Society 2019; (19(2)):276-284 doi:10.1016/j.spinee.2018.06.006.
PMID: 29906618 - 4
Clinical characteristics and management differences for grade II and III spinal meningiomas.
Krauss WE, Yolcu YU, Alvi MA, et al.
Journal of neuro-oncology 2021; (153(2)):313-320 doi:10.1007/s11060-021-03771-1.
PMID: 33973145 - 5
Clinical features and surgical outcomes of primary spinal anaplastic meningioma: a cases series and literature review.
Wu L, Wang L, Zou W, et al.
Translational cancer research 2023; (12(5)):1325-1334 doi:10.21037/tcr-22-2505.
PMID: 37304540 - 6
Simpson Grade I-III Resection of Spinal Atypical (World Health Organization Grade II) Meningiomas is Associated With Symptom Resolution and Low Recurrence.
Sun SQ, Cai C, Ravindra VM, et al.
Neurosurgery 2015; (76(6)):739-46 doi:10.1227/NEU.0000000000000720.
PMID: 25774702 - 7
[Radiotherapy and spinal toxicity: News and perspectives].
Peyraga G, Ducassou A, Arnaud FX, et al.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2021; (25(1)):55-61 doi:10.1016/j.canrad.2020.05.017.
PMID: 33303351 - 8
Pathobiology of radiation myelopathy and strategies to mitigate injury.
Wong CS, Fehlings MG, Sahgal A
Spinal cord 2015; (53(8)):574-80 doi:10.1038/sc.2015.43.
PMID: 25800695 - 9
Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y, Xu L, Zhuang H, et al.
Cancer medicine 2019; (8(14)):6176-6184 doi:10.1002/cam4.2546.
PMID: 31489788 - 10
Assessment of the treatment response of spinal meningiomas after radiosurgery focusing on serial MRI findings.
Lee ME, Hwang YJ, Sohn MJ, et al.
Japanese journal of radiology 2015; (33(9)):547-58 doi:10.1007/s11604-015-0455-9.
PMID: 26170044 - 11
Radiation Myelitis Risk After Hypofractionated Spine Stereotactic Body Radiation Therapy.
Jackson CB, Boe LA, Zhang L, et al.
JAMA oncology 2025; (11(2)):128-134 doi:10.1001/jamaoncol.2024.5387.
PMID: 39699884 - 12
Radiation myelopathy following stereotactic body radiation therapy for spine metastases.
Ong WL, Wong S, Soliman H, et al.
Journal of neuro-oncology 2022; (159(1)):23-31 doi:10.1007/s11060-022-04037-0.
PMID: 35737172
This page is for informational purposes only and does not constitute medical advice. Your neurosurgeon and radiation oncologist can explain whether radiation is appropriate for your spinal meningioma and discuss spinal-cord risks.